Phase II biomarker study of oral dexpramipexole in moderate to severe eosinophilic asthma Aug. 20, 2019 No Comments
CureVac, Yale to jointly discover mRNA-based candidates for pulmonary diseases Aug. 14, 2019 No Comments
Positive phase II data presented for dry powder inhaler formulation of ensifentrine Aug. 5, 2019 No Comments
Arcturus receives additional support from CF Foundation to develop mRNA therapies to treat CF Aug. 5, 2019 No Comments
Translate Bio reports interim data from phase I/II trial of MRT-5005 in cystic fibrosis July 31, 2019 No Comments
RSS